HealthEquity (HQY) Tops Q2 EPS by 12c, Sales Rise 29%; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Oppenheimer Remains Bullish on HealthEquity (HQY) Following Solid 2Q
September 6, 2017 9:44 AM EDTOppenheimer reiterated an Outperform rating and $61.00 price target on HealthEquity, Inc (NASDAQ: HQY) following the company's 2Q earnings report. Revenues of $56.9M beat estimates of $55.8M and adjusted EPS of $0.27 beat estimates of $0.18, mainly on tax benefits.
HQY raised its FY18... More
